This Fund Just Viridian: Key Takeaways for Investors
A major fund recently trimmed its stake in Viridian Therapeutics, signaling potential rotation rather than a verdict ...
Assess which is better for you: index funds or active funds, focusing on costs, performance consistency, and your investment horizon.
24,613 articlesA major fund recently trimmed its stake in Viridian Therapeutics, signaling potential rotation rather than a verdict ...
A major hedge fund just plowed a substantial stake into a gene-editing company, signaling conviction in Beam Therapeu...
A new Belden stake filed with the SEC shows an investment firm buying $89.5 million worth of shares. This article bre...
Two high-yield closed-end funds are sparking debate as one slashes distributions and the other maintains payments. He...
A major move by a prominent asset manager reveals how large portfolios tweak biotech bets. Learn what the trim means ...
Two leading midstream ETFs, AMLP and MLPX, battle for income and tax efficiency as the 2026 energy rally persists. Th...
Spot XRP ETFs are gaining momentum in 2026, pulling in about $1.75 billion in cumulative inflows and amassing roughly...
As retirement nears, the choice between Original Medicare and Medicare Advantage becomes personal. This piece shares ...
Chipotle and Wingstop diverged sharply this year, with Chipotle facing softer traffic and Wingstop leveraging its fra...
Three cruise stocks rise and fall on 2025 results and 2026 guidance. This report weighs Royal Caribbean, Carnival, an...
Apple posts strong hardware momentum and record services, while Palantir accelerates AI platform growth. The debate c...
A pop icon’s throwback moment highlights how childhood interests shape our finances. This guide shows practical ways ...